Abstrakt

Przypisy

• 1. Benzing T., Simons M., Walz G.: Wnt signaling in polycystic kidneydisease. J. Am. Soc. Nephrol., 2007; 18: 1389-1398
  Google Scholar
• 2. Buraczynska M., Swatowski A., Markowska-Gosik D.: Transcriptionfactor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res. Clin.Pract., 2011; 93: 390-395
  Google Scholar
• 3. Cauchi S., Meyre D., Choquet H., Dina C., Born C, Marre M., BalkauB., Froguel P.; DESIR Study Group.: TCF7L2 variation predictsReferenceshyperglycemia incidence in a French general population: the datafrom an epidemiological study on the Insulin Resistance Syndrome(DESIR) study. Diabetes, 2006; 55: 3189-3192
  Google Scholar
• 4. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S.,Balkau B., Charpentier G., Pattou F., Stetsyuk V., Scharfmann R., StaelsB., Frühbeck G., Froguel P.: Transcription factor TCF7L2 geneticstudy in the French population: expression in human beta-cells andadipose tissue and strong association with type 2 diabetes. Diabetes,2006; 55: 2903-2908
  Google Scholar
• 5. Damcott C.M., Pollin T.I., Reinhart L.J., Ott S.H., Shen H., SilverK.D., Mitchell B.D., Shuldiner A.R.: Polymorphisms in the transcriptionfactor 7-like 2 (TCF7L2) gene are associated with type 2 diabetesin the Amish: replication and evidence for a role in both insulin secretionand insulin resistance. Diabetes, 2006; 55: 2654-2659
  Google Scholar
• 6. Eastman Q., Grosschedl R.: Regulation of LEF-1/TCF transcriptionfactors by Wnt and other signals. Curr. Opin. Cell. Biol., 1999;11: 233-240
  Google Scholar
• 7. Eikmans M., Aben J.A., Koop K., Baelde H.J., de Heer E., BruijnJ.A.: Genetic factors in progressive renal disease: the good ones,the bad ones and the ugly ducklings. Nephrol. Dial. Transplant.,2006; 21: 257-260
  Google Scholar
• 8. Ewens W.J., Spielman R.S.: The transmission/disequilibrium test: history,subdivision, and admixture. Am. J. Hum. Genet., 1995; 57: 455-464
  Google Scholar
• 9. Ewens W.J., Spielman R.S.: What is the significance of a significantTDT? Hum. Hered., 2005; 60: 206-210
  Google Scholar
• 10. Florez J.C., Jablonski K.A., Bayley N., Pollin T.I., de Bakker P.I.,Shuldiner A.R., Knowler W.C., Nathan D.M., Altshuler D., DiabetesPrevention Program Research Group: TCF7L2 polymorphisms andprogression to diabetes in the Diabetes Prevention Program. N. Engl.J. Med., 2006; 355: 241-250
  Google Scholar
• 11. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., ManolescuA., Sainz J., Helgason A., Stefansson H., Emilsson V., HelgadottirA., Styrkarsdottir U., Magnusson K.P., Walters G.B., PalsdottirE., Jonsdottir T. et al.: Variant of transcription factor 7-like 2 (TCF7L2)gene confers risk of type 2 diabetes. Nat. Genet., 2006; 38: 320-323
  Google Scholar
• 12. Körner A., Berndt J., Stumvoll M., Kiess W., Kovacs P.: TCF7L2gene polymorphisms confer an increased risk for early impairmentof glucose metabolism and increased height in obese children. J. Clin.Endocrinol. Metab., 2007; 92: 1956-1960
  Google Scholar
• 13. Köttgen A., Hwang S.J., Rampersaud E., Coresh J., North K.E.,Pankow J.S., Meigs J.B., Florez J.C., Parsa A., Levy D., Boerwinkle E.,Shuldiner A.R., Fox C.S., Kao W.H.: TCF7L2 variants associate withCKD progression and renal function in population-based cohorts. J.Am. Soc. Nephrol., 2008; 19: 1989-1999
  Google Scholar
• 14. Luttropp K., Lindholm B., Carrero J.J., Glorieux G., Schepers E.,Vanholder R., Schalling M., Stenvinkel P., Nordfors L.: Genetics/genomicsin chronic kidney disease-towards personalized medicine?Semin. Dial., 2009; 22: 417-422
  Google Scholar
• 15. Mayans S., Lackovic K., Lindgren P., Ruikka K., Agren A., EliassonM., Holmberg D.: TCF7L2 polymorphisms are associated with type 2diabetes in northern Sweden. Eur. J. Hum. Genet., 2007; 15: 342-346
  Google Scholar
• 16. Melzer D., Murray A., Hurst A.J., Weedon M.N., Bandinelli S., CorsiA.M., Ferrucci L., Paolisso G., Guralnik J.M., Frayling T.M.: Effects ofthe diabetes linked TCF7L2 polymorphism in a representative olderpopulation. BMC Med., 2006; 4: 34-42
  Google Scholar
• 17. Moczulski D., Gawlik B., August R.: TCF7L2 gene is associatedwith type 2 diabetes in Polish population. Diabet. Dośw. Klin., 2007;2: 109-114
  Google Scholar
• 18. Munoz J., Lok K.H., Gower B.A., Fernandez J.R., Hunter G.R., Lara-CastroC., De Luca M., Garvey W.T.: Polymorphism in the transcriptionfactor 7-like 2 (TCF7L2) gene is associated with reduced insulinsecretion in nondiabetic women. Diabetes, 2006; 55: 3630-3644
  Google Scholar
• 19. National Kidney Foundation: K/DOQI Clinical Practice Guidelinesfor Chronic Kidney Disease: Evaluation, Classification and Stratification.Am. J. Kidney Dis., 2002; 39, suppl. 1: S1-S266
  Google Scholar
• 20. Nguyen S., Hsu C.Y.: Excess weight as a risk factor for kidneyfailure. Curr. Opin. Nephrol. Hypertens., 2007; 16: 71-76
  Google Scholar
• 21. Remuzzi G., Benigni A., Remuzzi A.: Mechanisms of progressionand regression of renal lesions of chronic nephropathies and diabetes.J. Clin. Invest., 2006; 116: 288-296
  Google Scholar
• 22. Saxena R., Gianniny L., Burtt N.P., Lyssenko V., Giuducci C.,Sjögren M., Florez J.C., Almgren P., Isomaa B., Orho-Melander M.,Lindblad U., Daly M. J., Tuomi T., Hirschhorn J.N., Ardlie K.G., GroopL.C., Altshuler D.: Common single nucleotide polymorphisms inTCF7L2 are reproducibly associated with type 2 diabetes and reducethe insulin response to glucose in nondiabetic individuals. Diabetes,2006; 55: 2890-2895
  Google Scholar
• 23. Schedl A.: Renal abnormalities and their developmental origin.Nat. Rev. Genet., 2007; 8: 791-802
  Google Scholar
• 24. Tong Y., Lin Y., Zhang Y., Yang J., Zhang Y., Liu H., Zhang B.: Associationbetween TCF7L2 gene polymorphisms and susceptibilityto type 2 diabetes mellitus: a large Human Genome Epidemiology(HuGE) review and meta-analysis. BMC Med Genet., 2009; 19: 10-15
  Google Scholar

Pełna treść artykułu